Nautilus Biotechnology
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAUT and other ETFs, options, and stocks.About NAUT
Nautilus Biotechnology, Inc. is a development stage life sciences company, which creates platform technology for quantifying and unlocking the complexity of the proteome. Its products include Proteome Analysis System, Reagent Kits, and Software and Analysis.
CEOSujal M. Patel
CEOSujal M. Patel
Employees155
Employees155
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2016
Founded2016
Employees155
Employees155
NAUT Key Statistics
Market cap260.19M
Market cap260.19M
Price-Earnings ratio-4.07
Price-Earnings ratio-4.07
Dividend yield—
Dividend yield—
Average volume259.90K
Average volume259.90K
High today$2.35
High today$2.35
Low today$2.02
Low today$2.02
Open price$2.05
Open price$2.05
Volume109.91K
Volume109.91K
52 Week high$2.54
52 Week high$2.54
52 Week low$0.62
52 Week low$0.62
Stock Snapshot
As of today, Nautilus Biotechnology(NAUT) shares are valued at $2.06. The company's market cap stands at 260.19M, with a P/E ratio of -4.07.
As of 2025-12-09, Nautilus Biotechnology(NAUT) stock has fluctuated between $2.02 and $2.35. The current price stands at $2.06, placing the stock +2.2% above today's low and -12.3% off the high.
Nautilus Biotechnology(NAUT) shares are trading with a volume of 109.91K, against a daily average of 259.9K.
During the past year, Nautilus Biotechnology(NAUT) stock moved between $0.62 at its lowest and $2.54 at its peak.
During the past year, Nautilus Biotechnology(NAUT) stock moved between $0.62 at its lowest and $2.54 at its peak.
People also own
Based on the portfolios of people who own NAUT. This list is generated using Robinhood data, and it’s not a recommendation.